FIELD: medical science.
SUBSTANCE: invention relates to medicine, specifically to endocrinology, therapy, and can be used to prevent an unsatisfactory long-term treatment result of diabetic foot syndrome after a surgical intervention, characterized by that postmenopausal patients take menopausal hormonal therapy 17-β-oestradiol in dose of 1 mg a day in a combination with dydrogesterone in dose of 5 mg a day after surgical treatment daily for 1 year.
EFFECT: invention provides preventing the unsatisfactory postoperative remote therapeutic effect in purulent-necrotic complications of diabetic foot syndrome.
1 cl, 7 dwg, 5 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTING SURGICAL TACTICS WHEN TREATING THE CASES OF DIABETIC FOOT SYNDROME | 2005 |
|
RU2299700C1 |
| METHOD FOR GENE THERAPY TREATMENT OF DIABETIC FOOT SYNDROME | 2015 |
|
RU2599507C1 |
| METHOD FOR TREATING MENOPAUSAL SYNDROME WITH COMBINATION OF XENON THERAPY AND GENERAL CRYOTHERAPY | 2023 |
|
RU2804583C1 |
| METHOD OF SURGICAL TREATMENT OF FOOT AT PURULENT-NECROTIC LESIONS AGAINST DIABETIC ANGIONEUROPATHY | 2007 |
|
RU2343869C1 |
| METHOD FOR PERSONALISING THERAPY OF AN ULCEROUS DEFECT IN DIABETIC FOOT SYNDROME | 2021 |
|
RU2785531C1 |
| METHOD OF TREATING GENITOURINARY SYNDROME IN MENOPAUSAL WOMEN BY MEANS OF PLACENTAL THERAPY | 2019 |
|
RU2710015C1 |
| METHOD FOR CORRECTION OF DYSLIPIDEMIA IN WOMEN WITH METABOLIC SYNDROME DURING MENOPAUSAL TRANSITION | 2021 |
|
RU2771426C1 |
| METHOD FOR SURGICAL TACTICS SELECTION DURING DIABETIC FOOT TREATMENT | 2016 |
|
RU2621945C1 |
| METHOD OF TREATING OSTEOPENIC SYNDROME IN POSTMENOPAUSAL OBESITY WOMEN | 2017 |
|
RU2698269C2 |
| METHOD FOR TREATING NEUROISCHEMIC DIABETIC FOOT SYNDROME | 2020 |
|
RU2754415C1 |
